Provides consensus-based guidelines to enhance the quality of pharmacodynamic studies of neuromuscular blocking agents.
Answers are grounded in this paper and cite their sources.
Establishes GCRP standards for neuromuscular blocker pharmacodynamic studies; extends consensus to improve research quality and clinical evidence translation.
Based on an international consensus conference held in Copenhagen in the autumn of 1994, a set of guidelines for Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents are presented. The guidelines are intended to be a help for people working in this research field, and it is hoped that the guidelines will assist researchers, editors, and drug companies to enhance the quality of their pharmacodynamic studies of neuromuscular blocking agents.
No takes yet. Share an insight, caveat, or question.
Viby‐Mogensen et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: